Adawi Kamal

CIK 00017883932 companiesSAN DIEGO, CA

Transactions

Companies

Filings

CIK

0001788393

Recent Transactions

17 trades

Award
FATE THERAPEUTICS INC$FATE
Common Stock
2026-01-15+25,000→ 100,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2026-01-15+75,000→ 75,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2025-10-20+375,000→ 375,000 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2025-10-20+75,000→ 75,000 total
Sale
EXAGEN INC.$XGN
Common Stock
2024-03-04$1.91/sh−9,297→ 247,236 total
Sale
EXAGEN INC.$XGN
Common Stock
2024-03-04$1.91/sh−3,487→ 243,749 total
Award
EXAGEN INC.$XGN
Common Stock
2024-02-20+75,000→ 256,533 total
Sale
EXAGEN INC.$XGN
Common Stock
2024-02-06$1.95/sh−6,738→ 181,533 total
Sale
EXAGEN INC.$XGN
Common Stock
2023-03-02$2.30/sh−3,667→ 188,271 total
Award
EXAGEN INC.$XGN
Common Stock
2023-02-27+100,000→ 191,938 total
Sale
EXAGEN INC.$XGN
Common Stock
2023-02-08$2.69/sh−5,821→ 91,938 total
Tax Payment
EXAGEN INC.$XGN
Common Stock
2022-03-01$7.12/sh−3,241→ 97,759 total
Award
EXAGEN INC.$XGN
Common Stock
2022-02-04+63,500→ 101,000 total
Award
EXAGEN INC.$XGN
Common Stock
2021-02-23+37,500→ 37,500 total
Award
EXAGEN INC.$XGN
Stock Option(right to buy)
2021-02-23+12,500→ 12,500 total
Award
EXAGEN INC.$XGN
Stock Option(right to buy)
2020-01-09+52,500→ 52,500 total
Award
EXAGEN INC.$XGN
Stock Option (right to buy)
2019-09-18+21,635→ 21,635 total

C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE

SAN DIEGO, CA, 92131